Article
Ending DIR Fees Could Save Medicare Billions Tops SPT Week in Review
Author(s):
Top news of the week from Specialty Pharmacy Times.
5. It’s Not ‘Just A Uterine Fibroid’
In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma. Read more…
4. Rapid Hepatitis C Testing Improves Quality of Life Among Young Adults
Same-day results increase the number of individuals who get tested and treated for HCV. Read more…
3. FDA Approves Abemaciclib for Advanced, Metastatic Breast Cancer
Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy. Read more…
2. Humira Litigation Comes to a Close, Clearing Path to Biosimilar Launch
AbbVie grants commercialization rights to Amjevita. Read more…
1. Study: Ending DIR Fees Could Save Medicare Billions
The Improving Transparency and Accuracy in Medicare Part D Spending Act would end direct and indirect remuneration fees. Read more…
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
